Clinical trials in patients with metabolic syndrome reveal that L-Carnitine supplementation of 2 g/day for extended periods (25-50 weeks) significantly reduces fasting blood glucose, HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), inflammatory markers including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-), and triglyceride levels
(PubMed) Diesel B, Kulhanek-Heinze S, Holtje M, et al
LifeMD is focusing on partnerships with leading pharmaceutical manufacturers as part of its growth strategy and aims to provide accessible, high-quality obesity and metabolic care
The one-star reviews tell a different story, but the pattern is clear
2 Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran